Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

President Donald Trump's administration has placed a freeze on information being released from government health agencies.

David Hasan, MD, MSc, a practicing neurosurgeon in the US, discusses how he provided health care in a conflict zone on 2 separate missions to Gaza.

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Childhood BMI trends — specifically moderate BMI and high BMI variability — were associated with high cortisol concentrations at 17 years of age.

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

HealthDay News — The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to a study published online Jan. 13 in the Journal of General ...

Provepharm Inc. is recalling 1 lot of Phenylephrine HCl Injection, USP 10mg/mL due to presence of particulate matter in the product.

For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes.

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

There is decreased risk for MACE, stroke, and mortality in patients with newly diagnosed atrial fibrillation who regularly use statins.